| Darolutamide in nonmetastatic, castration-resistant prostate cancer K Fizazi, N Shore, TL Tammela, A Ulys, E Vjaters, S Polyakov, M Jievaltas, ... NEW ENGLAND JOURNAL OF MEDICINE (0028-4793 / 1533-4406) 380 (13), 1235-46, 2019 | 892 | 2019 |
| Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide K Fizazi, N Shore, TL Tammela, A Ulys, E Vjaters, S Polyakov, M Jievaltas, ... NEW ENGLAND JOURNAL OF MEDICINE (0028-4793 / 1533-4406) 383 (11), 1040-49, 2020 | 313 | 2020 |
| Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer C Castilla, B Congregado, JM Conde, R Medina, FJ Torrubia, MÁ Japón, ... UROLOGY (0090-4295 / 1527-9995) 76 (4), 1017, 2010 | 87 | 2010 |
| Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study A Alcaraz, J Carballido-Rodríguez, M Unda-Urzaiz, R Medina-López, ... International urology and nephrology 48 (5), 645-656, 2016 | 82 | 2016 |
| Bladder cancer in Spain 2011: population based study B Miñana, JM Cózar, J Palou, M Unda Urzaiz, RA Medina-Lopez, ... The Journal of urology 191 (2), 323-328, 2014 | 55 | 2014 |
| Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study MJ Ribal, L Mengual, JJ Lozano, M Ingelmo-Torres, J Palou, ... European journal of cancer 54, 131-138, 2016 | 49 | 2016 |
| Mycotic pseudoaneurysm following a kidney transplant: a case report and review of the literature I Osman, R Barrero, E León, R Medina, F Torrubia PEDIATRIC TRANSPLANTATION (1397-3142 / 1399-3046) 13 (5), 615-19, 2009 | 32 | 2009 |
| Prostate cancer cell response to Paclitaxel is affected by abnormally expressed securin PTTG1 C Castilla, ML Flores, R Medina, B Pérez-Valderrama, F Romero, ... MOLECULAR CANCER THERAPEUTICS (1535-7163 / 1538-8514) 13 (10), 2372-83, 2014 | 31 | 2014 |
| Castration-resistant metastatic prostate cancer: current status and treatment possibilities J Carles, D Castellano, MÁ Climent, P Maroto, R Medina, A Alcaraz CLINICAL & TRANSLATIONAL ONCOLOGY (1699-048X / 1699-3055) 14 (3), 169-76, 2012 | 31 | 2012 |
| Obatoclax and paclitaxel synergistically induce apoptosis and overcome paclitaxel resistance in urothelial cancer cells R Jiménez-Guerrero, J Gasca, ML Flores, B Pérez-Valderrama, ... CANCERS (2072-6694) 10 (12), 490, 2018 | 29 | 2018 |
| PARP Inhibitors: A New Horizon for Patients with Prostate Cancer B Congregado, I Rivero, I Osmán, C Sáez, R Medina López Biomedicines 10 (6), 1416, 2022 | 28 | 2022 |
| Radical prostatectomy after vascular targeted photodynamic therapy with padeliporfin: feasibility, and early and intermediate results V Pierrard, S Lebdai, F Kleinclauss, AR Azzouzi, JE Terrier, E Fortier, ... The Journal of Urology 201 (2), 315-321, 2019 | 24 | 2019 |
| Loss of PKCδ induces prostate cancer resistance to Paclitaxel through activation of Wnt/beta-catenin pathway and Mcl-1 accumulation ML Flores, C Castilla, J Gasca, R Medina, B Pérez-Valderrama, F Romero, ... MOLECULAR CANCER THERAPEUTICS (1535-7163 / 1538-8514) 15 (7), 1713-1725, 2016 | 23 | 2016 |
| Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells C Castilla, ML Flores, JM Conde, R Medina, FJ Torrubia, MÁ Japón, ... CLINICAL & EXPERIMENTAL METASTASIS (0262-0898 / 1573-7276) 29 (4), 349-358, 2012 | 22 | 2012 |
| Measurement of urine pH for epidemiological studies on bladder cancer J Alguacil, RM Pfeiffer, LE Moore, MR Del Fresno, R Medina-Lopez, ... European journal of epidemiology, 91-98, 2007 | 21 | 2007 |
| PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells C Castilla, D Chinchón, R Medina, FJ Torrubia, MÁ Japón, C Sáez CELL DEATH & DISEASE (2041-4889) 4, e576, 2013 | 20 | 2013 |
| Key areas in the learning curve for robotic urological surgery: a Spanish multicentre survey Urologia Internationalis (0042-1138 / 1423-0399) 87 (1), 64-69, 2011 | 19* | 2011 |
| Clinical benefit of tamsulosin and the hexanic extract of Serenoa repens, in combination or as monotherapy, in patients with moderate/severe LUTS-BPH: a subset analysis of the … A Alcaraz, A Rodríguez-Antolín, J Carballido-Rodríguez, D Castro-Díaz, ... Journal of clinical medicine 9 (9), 2909, 2020 | 18 | 2020 |
| Cáncer de próstata resistente a castración:¿ hacia dónde vamos? A Alcaraz, R Medina, P Maroto, MA Climent, D Castellano, J Carles Actas Urológicas Españolas 36 (6), 367-374, 2012 | 18* | 2012 |
| Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma C Garrigós, M Espinosa, A Salinas, I Osman, R Medina, M Taron, ... Oncotarget 8 (63), 106551, 2017 | 17 | 2017 |
Antonio AlcarazCap de Servei UrologiaVerified email at clinic.ub.es
